Rhythm Pharmaceuticals Inc (RYTM) — Long-term Investment Intensity
Rhythm Pharmaceuticals Inc (RYTM) has a Long-term Investment Intensity of 5.0% as of June 2023. Long-term investments of $15.52 Million represent 5.0% of total assets of $309.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Rhythm Pharmaceuticals Inc net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Rhythm Pharmaceuticals Inc Long-term Investment Intensity (2015–2022)
This chart shows how Rhythm Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2022. As of June 2023, the intensity stands at 5.0%, reflecting long-term investments of $15.52 Million against total assets of $309.94 Million USD. Also explore how large is Rhythm Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Rhythm Pharmaceuticals Inc (2015–2022)
The table below presents the year-by-year Long-term Investment Intensity for Rhythm Pharmaceuticals Inc from 2015 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Rhythm Pharmaceuticals Inc (RYTM) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 4.4% | $16.66 Million | $382.48 Million | ▲ +0.8 pp |
| 2021 | 3.6% | $11.81 Million | $329.52 Million | ▲ +3.4 pp |
| 2015 | 0.2% | $60.00K | $37.27 Million | — |